Neuroimaging and blood markers as indicators of ketamine efficacy in treatment resistant depression

  • Coffey, Eleanor (Principal Investigator)
  • Walter, Martin (Co-Principal Investigator)
  • Sartorius, Alexander (Principal Investigator)
  • Lecourtier, Lucas (Principal Investigator)

Project Details

Description

This is a ERANET funded clinical study to identify predictive markers for ketamine treatment.
Short titleNEUROMARKET
StatusFinished
Effective start/end date01/04/2031/03/23

Funding

  • Research Council of Finland